Identifying reversible psychiatric dementia mimics in new memory clinic outpatients

Michitaka Funayama1,2,3, Shin Kurose1,2,3, Taketo Takata1,3

  • 1Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, Japan.

Abstract

Insights

Reversible psychiatric conditions can mimic dementia, but are rare. Comprehensive memory clinic evaluations are crucial, especially for younger patients with rapid cognitive decline.

Area of Science:

  • Neurology
  • Psychiatry
  • Cognitive Science

Background:

  • Identifying reversible conditions mimicking dementia is vital in memory clinics.
  • Psychiatric conditions as dementia mimics are less studied than neurological ones, with limited data on reversibility.

Purpose of the Study:

  • To identify reversible psychiatric conditions that mimic dementia.

Main Methods:

  • A retrospective chart review of 749 new outpatients was performed.
  • Investigated etiologies, progression rates, cognitive and functional levels, and reversibility of psychiatric and neurological conditions.
  • Identified cases with cognitive reversibility post-treatment.

Main Results:

  • 121 individuals (16.2%) had potentially reversible conditions (75 psychiatric, 46 neurological).
  • Psychiatric mimics were younger, had faster progression, and higher cognitive function than non-mimics.
  • Only 6 individuals (0.9%) showed cognitive improvement, including two with psychiatric conditions.

Conclusions:

  • Reversible psychiatric dementia mimics are rare but emphasize comprehensive memory clinic evaluations.
  • Crucial for younger individuals with rapid cognitive decline.
  • Infrequency of reversibility may link to dementia risk factors or prodromal roles.

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
78
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
399
Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
85
False Memories01:18

False Memories

False memories represent a cognitive distortion in which individuals recall events that did not happen, or remember them in an altered form. This phenomenon highlights the brain's constructive nature in processing and recalling memories, emphasizing that memory is not a perfect representation of past events but rather a dynamic reconstruction influenced by various factors.
One primary source of false memories is misattribution, where individuals incorrectly associate external information...
61
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
137
Dissociative Amnesia01:21

Dissociative Amnesia

Dissociative amnesia is a complex psychological condition that manifests as an inability to recall personal information, often tied to traumatic or stressful events. Unlike general amnesia, individuals with this condition retain the ability to perform routine activities and procedural tasks, such as operating a phone or navigating public transportation, yet experience profound gaps in autobiographical memory. These lapses may encompass significant life events, such as suicide attempts or...
31